Is diagnosis-specific graded prognostic assessment score valid in patients with brain metastases treated in routine clinical practice in two European countries?
DS-GPA is a valid prognostic score that might improve shared decision making as well as patient stratification in prospective clinical trials.
Each biopsy was associated with a significant risk of complications compared to randomly selected controls. However, the repeat biopsy procedure itself was not associated with a greater risk of serious complications requiring hospital admission compared to the initial biopsy.